COVID-19 patients failing to regain consciousness require neurological assessment.
•
Brain imaging and lumbar puncture are required to determine CNS involvement.
•
Neurological involvement during COVID-19 infection can be immune mediated.
•
Plasmapheresis can be beneficial in COVID-19 patients with autoimmune encephalitis.
Abstract
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).